Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | F12 | P00748 | 1/20 | 0.45 |
| ▸ | NCF1 | P14598 | 1/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | CCR1 | P32246 | 4/20 | 0.42 |
| ▸ | CCR8 | P51685 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5478954 | 1.00 | CYP1A2 (0.48) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL29475320 | 0.91 | CYP1A2 (0.44) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL5471458 | 0.91 | CYP1A2 (0.44) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL30022648 | 0.91 | CYP1A2 (0.44) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL2825543 | 0.91 | PLAU (0.45) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL30421514 | 0.89 | CYP1A2 (0.43) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL9999520 | 0.87 | CYP1A2 (0.41) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL24732486 | 0.81 | L3MBTL1 (0.48) | CYP1A2ALDH1A1HPGDHSD17B10THRB | |
| SCHEMBL14511176 | 0.79 | CCR1 (0.41) | CYP1A2ALDH1A1HPGDHSD17B10PLAU | |
| SCHEMBL9999522 | 0.78 | CYP1A2 (0.47) | CYP1A2ALDH1A1HPGDHSD17B10THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022138-A1 | METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE | CONWAY DAVID JONATHAN (US) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022138-A1 | METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE | TRPV3, VDR, TRPC3 | CYP1A2 3850/4885ALDH1A1 2567/4885HPGD 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.